Connecticut Light and Power C&LM Programs/Residential Load Management Services Program: 2002 Summer and Winter Thermostat Pilot Programs Impact Evaluation Report [PDF]
RLW Analytics, Inc.
core +1 more source
On the expansion of analytic functions in series of polynomials [PDF]
J. L. Walsh
openalex +1 more source
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
Big data analytics and machine learning in hematology: Transformative insights, applications and challenges. [PDF]
Obeagu EI+3 more
europepmc +1 more source
THE ELECTRO-TITRAMETRÍC METHOD AND ITS APPLICATION TO GENERAL ANALYTICAL CHEMISTRY. [PDF]
F. H. Hesselink van. Suchtelen+1 more
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
From Managers to Machines: A Reply to Respondents
Karen Yeung
doaj +1 more source
Supervising Trainee Inter-Visit Care Using EHR Learning Analytics: Formative Training Tool or Threat to Well-Being? [PDF]
Boggs Z, Frazier H, Kon R.
europepmc +1 more source
ANALYTICAL CHEMISTRY. VOL. II. QUANTITATIVE ANALYSIS. [PDF]
E. T. Allen
openalex +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source